Showing results (371-380 of 853) with videos related to

Sort By:
Pageof 86
Nature Communications|December 16, 2023
Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulationCarlos K H Wong, Jonathan J Lau, Ivan C H Au, et al.
The Journal of Clinical Investigation|July 30, 2019
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomesRudragouda Channappanavar, Anthony R Fehr, Jian Zheng, et al.
Journal of Virology|May 6, 2011
Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 virusesWendy C L Yu, Renee W Y Chan, Jieru Wang, et al.
Emerging Infectious Diseases|April 21, 2022
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic RiskJonathan Tin Lai Cheung, Tim K Tsang, Hui-Ling Yen, et al.
The Journal of Infectious Diseases|April 5, 2022
Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in ChildrenWeijia Xiong, Tim K Tsang, Ranawaka A P M Perera, et al.
Emerging Infectious Diseases|October 2, 2008
Effects of school closures, 2008 winter influenza season, Hong KongBenjamin J Cowling, Eric H Y Lau, Conrad L H Lam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccineBenjamin J Cowling, Vicky J Fang, Hiroshi Nishiura, et al.
Epidemiology (Cambridge, Mass.)|October 3, 2015
Interpreting Seroepidemiologic Studies of Influenza in a Context of Nonbracketing SeraTim K Tsang, Vicky J Fang, Ranawaka A P M Perera, et al.
Vaccine|January 24, 2026
Estimates of SARS-CoV-2 vaccine effectiveness against COVID-19-associated hospitalisation in paediatric patients in Hong Kong during two successive SARS-CoV-2 epidemic waves dominated by the Omicron variant: A test-negative design studyGeorge N Okoli, Mike Y W Kwan, Eunice L Y Chan, et al.
Vaccine|June 25, 2013
Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/ChinaY H Connie Leung, Geraldine Luk, Sin-Fun Sia, et al.
Pageof 86